Policy Institute

Articulate the value of medical innovation and ensure patient access to therapies

Our policy focus

Medical innovation

We strive to educate the public on the value of drug development to support increased innovation.  In addition, we seek to incentivize development of less marketable treatments

Patient access

We ensure equitable access to quality treatment for patients around the world and strive to increase access to early diagnosis and detection

RTWCF rare disease advisory board

We’ve assembled an advisory board to help guide us on priority areas and co-create opportunities for education, policy, and funding to support rare disease communities.